Source comparison
BPC-157 Biomarkers: Research vs Clinical Comparison
Inflammatory Cytokines (TNF-α, IL-6, IL-1β) 24–72 hours Serum or tissue ELISA Acute response. Not sustained effect Best for mechanism validation, not endpoint Angiogenesis Markers (VEGF, CD31 density) Days 5–14 Immunohistochemistry, ELISA Correlates with funct
This comparison does not assign a generated winner or score.
- Inflammatory Cytokines (TNF-α, IL-6, IL-1β)
- 24–72 hours
- Serum or tissue ELISA
- Acute response. Not sustained effect
- Best for mechanism validation, not endpoint
- Angiogenesis Markers (VEGF, CD31 density)
- Days 5–14
- Immunohistochemistry, ELISA
- Correlates with functional recovery
- Peak measurement at day 7–10 optimal
- Growth Factors (IGF-1, TGF-β, FAK-pY397)
- Days 10–21
- Western blot, ELISA
- Reflects structural rebuilding
- Requires tissue sampling. Serum less reliable
- Collagen Deposition
- Days 14–28
- Trichrome staining, hydroxyproline assay
- Direct structural outcome
- Endpoint measure, not mechanistic
- Histological Recovery
- Tissue sectioning, microscopy
- Visible outcome. Lags molecular response
- Standard but insufficient alone